ARPO - SEC Form 8-K filings

Aerpio Pharmaceuticals, Inc. filed SEC Form 8-K: Financial Statements and Exhibits (Amendment)

Aerpio Pharmaceuticals, Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

Aerpio Pharmaceuticals, Inc. filed SEC Form 8-K: Changes in Registrant’s Certifying Accountant, Leadership Update, Financial Statements and Exhibits

Aerpio Pharmaceuticals, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement

Aerpio Pharmaceuticals, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics, Regulation FD Disclosure, Financial Statements and Exhibits, Other Events

Aerpio Pharmaceuticals, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

Aerpio Pharmaceuticals, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

Aerpio Pharmaceuticals, Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

SEC Form 8-K filed by Aerpio Pharmaceuticals, Inc.

Aerpio Pharmaceuticals, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

Aerpio Pharmaceuticals, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

Aerpio Pharmaceuticals, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

Aerpio Pharmaceuticals, Inc. filed SEC Form 8-K: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits